CLOS
MDT icon

Compagnie Lombard Odier SCmA’s Medtronic MDT Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.77M Buy
112,761
+1,911
+2% +$183K 0.12% 85
2025
Q4 		$10.6M Buy
110,850
+10,720
+11% +$1.04M 0.12% 85
2025
Q3 		$9.54M Buy
100,130
+2,298
+2% +$211K 0.11% 89
2025
Q2 		$8.53M Sell
97,832
-4,859
-5% -$412K 0.11% 84
2025
Q1 		$9.23M Sell
102,691
-2,969
-3% -$266K 0.11% 89
2024
Q4 		$8.44M Buy
105,660
+24,914
+31% +$2.16M 0.12% 81
2024
Q3 		$7.27M Buy
80,746
+9,750
+14% +$820K 0.11% 87
2024
Q2 		$5.59M Buy
70,996
+44,450
+167% +$3.64M 0.09% 91
2024
Q1 		$2.31M Sell
26,546
-19,235
-42% -$1.64M 0.04% 127
2023
Q4 		$3.77M Sell
45,781
-32
-0.1% -$2.44K 0.07% 119
2023
Q3 		$3.59M Sell
45,813
-219
-0.5% -$18.3K 0.08% 109
2023
Q2 		$4.06M Sell
46,032
-36,500
-44% -$3.14M 0.11% 84
2023
Q1 		$6.65M Sell
82,532
-33,731
-29% -$2.75M 0.17% 80
2022
Q4 		$9.04M Buy
116,263
+12,247
+12% +$993K 0.24% 71
2022
Q3 		$8.4M Hold
104,016
– – 0.24% 63
2022
Q2 		$9.33M Sell
104,016
-1,859
-2% -$188K 0.24% 66
2022
Q1 		$11.7M Sell
105,875
-2,247
-2% -$237K 0.25% 65
2021
Q4 		$11.2M Sell
108,122
-581
-0.5% -$67.3K 0.22% 63
2021
Q3 		$13.6M Buy
108,703
+3,412
+3% +$442K 0.29% 62
2021
Q2 		$13.1M Sell
105,291
-685
-0.6% -$86K 0.29% 59
2021
Q1 		$12.5M Sell
105,976
-6,699
-6% -$785K 0.28% 74
2020
Q4 		$13.2M Sell
112,675
-6,635
-6% -$730K 0.34% 54
2020
Q3 		$12.4M Buy
119,310
+45
+0% +$4.52K 0.37% 50
2020
Q2 		$10.9M Buy
119,265
+7,100
+6% +$681K 0.37% 51
2020
Q1 		$10.1M Buy
112,165
+70,261
+168% +$7.47M 0.42% 50
2019
Q4 		$4.75M Sell
41,904
-70,617
-63% -$7.75M 0.18% 74
2019
Q3 		$12.2M Buy
112,521
+85
+0.1% +$8.87K 0.51% 48
2019
Q2 		$10.9M Sell
112,436
-949
-0.8% -$86.6K 0.44% 52
2019
Q1 		$10.3M Buy
113,385
+1,189
+1% +$106K 0.43% 56
2018
Q4 		$10.2M Sell
112,196
-935
-0.8% -$87.4K 0.42% 56
2018
Q3 		$11.1M Sell
113,131
-1,395
-1% -$129K 0.39% 56
2018
Q2 		$9.8M Buy
114,526
+1,184
+1% +$98.9K 0.36% 60
2018
Q1 		$9.09M Sell
113,342
-112,434
-50% -$9.27M 0.33% 62
2017
Q4 		$18.2M Buy
225,776
+112,066
+99% +$8.98M 0.33% 65
2017
Q3 		$8.84M Sell
113,710
-17,300
-13% -$1.44M 0.31% 66
2017
Q2 		$11.6M Sell
131,010
-699
-0.5% -$58.9K 0.4% 56
2017
Q1 		$10.6M Sell
131,709
-77,891
-37% -$6.08M 0.36% 67
2016
Q4 		$14.9M Sell
209,600
-11,118
-5% -$873K 0.44% 53
2016
Q3 		$19.1M Sell
220,718
-1,442
-0.6% -$126K 0.56% 45
2016
Q2 		$19.3M Buy
222,160
+503
+0.2% +$40.7K 0.56% 41
2016
Q1 		$16.6M Buy
+221,657
New +$16.7M 0.51% 45
2015
Q1 		– Sell
-162,563
Closed -$11.7M – 963
2014
Q4 		$11.7M Buy
162,563
+34,232
+27% +$2.38M 0.54% 40
2014
Q3 		$7.95M Buy
128,331
+34,493
+37% +$2.19M 0.32% 49
2014
Q2 		$5.98M Sell
93,838
-15,033
-14% -$913K 0.24% 63
2014
Q1 		$6.7M Sell
108,871
-1,289
-1% -$75.1K 0.28% 60
2013
Q4 		$6.32M Buy
+110,160
New +$6.25M 0.27% 63

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Compagnie Lombard Odier SCmA's MDT Position: Q1 2026 in Review

Compagnie Lombard Odier SCmA increased its Medtronic (MDT) stake by 1.7% in Q1 2026, buying an estimated $183K and bringing the position to 112,761 shares worth $9.77M. The position accounts for 0.12% of the portfolio, ranked #85.

Compagnie Lombard Odier SCmA first reported a position in MDT in Q4 2013 and has held it in 46 quarters since. The position peaked at $19.3M in Q2 2016. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Compagnie Lombard Odier SCmA held 112,761 shares of Medtronic worth $9.77M as of Q1 2026.
  • Compagnie Lombard Odier SCmA bought 1,911 Medtronic shares in Q1 2026, an estimated $183K.
  • Medtronic made up 0.12% of Compagnie Lombard Odier SCmA's portfolio in Q1 2026, its #85 holding.
  • Compagnie Lombard Odier SCmA first reported a position in Medtronic in Q4 2013 and has held it in 46 quarters since.
  • Compagnie Lombard Odier SCmA's Medtronic position peaked at $19.3M in Q2 2016.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2026, filed 15 Apr 2026.